There's fresh hope for early detection and new treatments of glaucoma, a group of eye diseases that have devastating effects ...

Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...

It's one of the most common causes of vision loss, and one of the easiest to overlook. Glaucoma symptoms develop so gradually ...

Ophthalmologists discuss how advanced imaging, MIGS, and home monitoring are reshaping decision-making in complex glaucoma ...

Founded to accelerate innovation in glaucoma treatment, Glaucoma 360 is GRF’s signature event and one of the vision community’s most anticipated annual gatherings. The three-day program features a ...

SIOUX FALLS, SD – November 04, 2025 – PRESSADVANTAGE – Glaucoma remains one of the leading causes of blindness in the United States, often progressing silently until vision loss has already occurred.

Synthetic cannabinoids and nicotinamide were among alternative treatment approaches discussed by Professor Augusto ...

BOZEMAN, MT – November 04, 2025 – PRESSADVANTAGE – Glaucoma continues to be one of the most significant causes of vision loss across the country, often developing slowly and without obvious warning ...

Nova Eye Medical ( ($AU:EYE) ) has provided an update. Nova Eye Medical Limited has announced an upcoming webinar featuring Dr. Mahmoud A. Khaimi, ...

Scientists developed a highly promising gene therapy to treat glaucoma -- a debilitating eye condition that can lead to complete vision loss, and which affects around 80 million people worldwide. The ...

Researchers have identified two molecules, agmatine and thiamine, that could enable early detection and potentially new treatments for the incurable eye disease, glaucoma.

Glaucoma creeps in without pain or obvious symptoms, slowly damaging your optic nerve. Regular eye exams and early detection ...